205 related articles for article (PubMed ID: 33291151)
1. Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever.
Kukuy OL; Beckerman P; Dinour D; Ben-Zvi I; Livneh A
Rheumatology (Oxford); 2021 Jul; 60(7):3235-3242. PubMed ID: 33291151
[TBL] [Abstract][Full Text] [Related]
2. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
[TBL] [Abstract][Full Text] [Related]
3. Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.
Yilmaz H; Inan O; Darcin T; Bilgic MA; Akcay A
Clin Exp Nephrol; 2015 Jun; 19(3):436-42. PubMed ID: 25059227
[TBL] [Abstract][Full Text] [Related]
4. AA amyloidosis complicating the hereditary periodic fever syndromes.
Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and survival in AA amyloidosis patients.
Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
[TBL] [Abstract][Full Text] [Related]
6. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
Bozaci I; Tatar E
Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
[TBL] [Abstract][Full Text] [Related]
7. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome.
Livneh A; Zemer D; Langevitz P; Laor A; Sohar E; Pras M
Arthritis Rheum; 1994 Dec; 37(12):1804-11. PubMed ID: 7986228
[TBL] [Abstract][Full Text] [Related]
8. Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome.
Cakar N; Yalçinkaya F; Ozkaya N; Tekin M; Akar N; Koçak H; Misirlioğlu M; Akar E; Tümer N
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S63-7. PubMed ID: 11760404
[TBL] [Abstract][Full Text] [Related]
9. Renal transplantation in patients with familial Mediterranean fever.
Erdem E; Karatas A; Kaya C; Dilek M; Yakupoglu YK; Arık N; Akpolat T
Clin Rheumatol; 2012 Aug; 31(8):1183-6. PubMed ID: 22562368
[TBL] [Abstract][Full Text] [Related]
10. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Assessment of Kidney Biopsies in Children with Familial Mediterranean Fever: A Single-Center Experience.
Yazılıtaş F; Çakıcı EK; Kurt Şükür ED; Özdel S; Arda N; Güngör T; Bülbül M
Nephron; 2020; 144(5):222-227. PubMed ID: 32172241
[TBL] [Abstract][Full Text] [Related]
12. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever.
Livneh A; Cabili S; Zemer D; Rabinovitch O; Pras M
J Rheumatol; 1993 Sep; 20(9):1519-23. PubMed ID: 8164208
[TBL] [Abstract][Full Text] [Related]
13. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
14. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever.
Altindal M; Turkmen E; Yildirim T; Yilmaz R; Aki FT; Arici M; Altun B; Erdem Y
Clin Transplant; 2016 Jul; 30(7):787-90. PubMed ID: 27101228
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
Hamanoue S; Suwabe T; Hoshino J; Sumida K; Mise K; Hayami N; Sawa N; Takaichi K; Fujii T; Ohashi K; Yazaki M; Ikeda S; Ubara Y
Mod Rheumatol; 2016 Jul; 26(4):610-3. PubMed ID: 25619282
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
17. Familial Mediterranean fever-associated renal amyloidosis: case report and review of the literature.
Andronesi AG; Ismail G; Gherghiceanu M; Mitroi G; Hârza MC
Rom J Morphol Embryol; 2019; 60(4):1299-1303. PubMed ID: 32239108
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.
Ben-Zvi I; Danilesko I; Yahalom G; Kukuy O; Rahamimov R; Livneh A; Kivity S
Isr Med Assoc J; 2012 Apr; 14(4):221-4. PubMed ID: 22675837
[TBL] [Abstract][Full Text] [Related]
19. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
Imamura S; Narita S; Nishikomori R; Tsuruta H; Numakura K; Maeno A; Saito M; Inoue T; Tsuchiya N; Nanjo H; Heike T; Satoh S; Habuchi T
BMC Res Notes; 2016 Oct; 9(1):473. PubMed ID: 27760547
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
Abedi AS; Nakhjavani JM; Etemadi J
Transplant Proc; 2013; 45(10):3502-4. PubMed ID: 24314942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
